Acrivon Therapeutics, Inc. Common Stock (ACRV) — Financial Flexibility Index
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a Financial Flexibility Index of -0.68x as of September 2025. Free cash flow of $-11.38 Million (operating CF $-12.28 Million minus capex $899.00K) represents -1% of total liabilities ($16.70 Million). Also explore ACRV net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Acrivon Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Acrivon Therapeutics, Inc. Common Stock across 5 annual periods. Check Acrivon Therapeutics, Inc. Common Stock (ACRV) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Acrivon Therapeutics, Inc. Common Stock (2020–2024)
Year-by-year free cash flow to debt coverage for Acrivon Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see ACRV company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.18x | $-62.90 Million | $-65.67 Million | $19.80 Million | ▼ -31.1% |
| 2023 | -2.42x | $-41.35 Million | $-42.64 Million | $17.07 Million | ▲ +6.8% |
| 2022 | -2.60x | $-27.95 Million | $-30.12 Million | $10.75 Million | ▼ -2366.6% |
| 2021 | -0.11x | $-13.74 Million | $-13.98 Million | $130.40 Million | ▲ +59.9% |
| 2020 | -0.26x | $-2.79 Million | $-2.80 Million | $10.60 Million | — |